Filter News
Area of Research
- (-) Neutron Science (1)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (3)
- Biology and Environment (4)
- Building Technologies (1)
- Clean Energy (26)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (1)
- Isotopes (5)
- Materials (4)
- Materials for Computing (3)
- Mathematics (1)
- Sensors and Controls (1)
- Supercomputing (2)
News Topics
- (-) Isotopes (1)
- (-) Nuclear Energy (3)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (1)
- Bioenergy (1)
- Biology (1)
- Biomedical (3)
- Composites (1)
- Computer Science (2)
- Coronavirus (1)
- Fusion (1)
- Materials (2)
- Materials Science (3)
- Molten Salt (2)
- Nanotechnology (2)
- Neutron Science (13)
- Physics (2)
- Quantum Science (1)
Media Contacts
Researchers from NASA’s Jet Propulsion Laboratory and Oak Ridge National Laboratory successfully created amorphous ice, similar to ice in interstellar space and on icy worlds in our solar system. They documented that its disordered atomic behavior is unlike any ice on Earth.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.